CLINICAL_TRIALS
trial_result
· 2017-09-08
Clinical Trial Update: Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) [Phase 4]
Summary
Phase 4 safety and tolerability study evaluating rapid dose titration of subcutaneous Remodulin in patients with pulmonary arterial hypertension. Results have b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2017-09-08